{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:09:57Z","timestamp":1791223797946,"version":"4.1.0"},"reference-count":105,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.ajog.2004.01.061","type":"journal-article","created":{"date-parts":[[2004,4,26]],"date-time":"2004-04-26T05:21:14Z","timestamp":1082956874000},"page":"S5-S22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":146,"special_numbering":"S","title":["Safety concerns and health benefits associated with oral contraception"],"prefix":"10.1016","volume":"190","author":[{"given":"Ronald","family":"Burkman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Schlesselman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Zieman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2004.01.061_BIB1","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(95)91926-0","article-title":"Venous thromboembolic disease and combined oral contraceptives: results of an international multicentre case-control study","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2004.01.061_BIB2","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0140-6736(97)02358-1","article-title":"Acute myocardial infarction and combined oral contraceptives: results of an international, multicentre, case-control study","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2004.01.061_BIB3","unstructured":"WHO. Cardiovascular Disease and Steroid Hormone Contraception: report of a WHO Scientific Group. Geneva, Switzerland: WHO Scientific Group on Cardiovascular Disease and Steroid Hormone Contraception; 1998. WHO Technical Report No. 877."},{"key":"10.1016\/j.ajog.2004.01.061_BIB4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/13625180008500402","article-title":"The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptives","volume":"5","author":"Nightingale","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.ajog.2004.01.061_BIB5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/oxfordjournals.aje.a115799","article-title":"Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease","volume":"133","author":"Gerstman","year":"1991","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2004.01.061_BIB6","first-page":"1","article-title":"Oral contraceptives and nonfatal vascular disease","volume":"66","author":"Porter","year":"1985","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.01.061_BIB7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/01443619509015499","article-title":"The risk of venous thromboembolism associated with low oestrogen oral contraceptives","volume":"15","author":"Farmer","year":"1995","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2004.01.061_BIB8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/ije\/21.1.48","article-title":"Risk factors for fatal venous thromboembolism in young women: a case- control study","volume":"21","author":"Thorogood","year":"1992","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ajog.2004.01.061_BIB9","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(94)90286-0","article-title":"Increased risk of venous thrombosis in oral contraceptive users who are carriers of factor V Leiden mutation","volume":"344","author":"Vandenbroucke","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2004.01.061_BIB10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0010-7824(96)00112-6","article-title":"The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women","volume":"54","author":"Lewis","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2004.01.061_BIB11","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0140-6736(95)91929-5","article-title":"Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen","volume":"346","author":"Bloemenkamp","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2004.01.061_BIB12","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(95)91928-7","article-title":"Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components","volume":"346","author":"Jick","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2004.01.061_BIB13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bmj.312.7023.83","article-title":"Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women","volume":"312","author":"Spitzer","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2004.01.061_BIB14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0140-6736(96)07496-X","article-title":"Population-based study of risk of venous thromboembolism associated with various oral contraceptives","volume":"349","author":"Farmer","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2004.01.061_BIB15","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1136\/bmj.321.7270.1190","article-title":"Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis","volume":"321","author":"Jick","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2004.01.061_BIB16","series-title":"Comprehensive gynecology","author":"Mishell","year":"1997"},{"key":"10.1016\/j.ajog.2004.01.061_BIB17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0010-7824(98)00020-1","article-title":"Blood coagulation and oral contraceptives: a critical review","volume":"57","author":"Winkler","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2004.01.061_BIB18","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(05)80081-9","article-title":"Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study","volume":"342","author":"Koster","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2004.01.061_BIB19","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJM199402243300801","article-title":"Resistance to activated protein C as a basis for venous thrombosis","volume":"330","author":"Svensson","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2004.01.061_BIB20","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0002-9378(97)70498-8","article-title":"Activated protein C resistance assay when applied in the general population","volume":"176","author":"Altes","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.01.061_BIB21","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0015-0282(99)00318-0","article-title":"Screening for factor V Leiden mutation before prescriving combination oral contraceptives","volume":"72","author":"Creinen","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2004.01.061_BIB22","first-page":"1034","article-title":"Evaluation of a new generation of oral contraceptives. The Advisory Board for the New Progestins","volume":"81","author":"Speroff","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.01.061_BIB23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/bmj.298.6667.165","article-title":"Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraceptive study","volume":"298","author":"Croft","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2004.01.061_BIB24","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/oxfordjournals.aje.a115592","article-title":"Oral contraceptive use and the risk of myocardial infarction","volume":"131","author":"Rosenberg","year":"1990","journal-title":"Am J Epidemiol"},{"issue":"Pt 2","key":"10.1016\/j.ajog.2004.01.061_BIB25","doi-asserted-by":"crossref","first-page":"S349","DOI":"10.1016\/S0002-9378(99)70695-2","article-title":"Cardiovascular disease: pathogenesis, epidemiology, and risk among users of oral contraceptives who smoke","volume":"180","author":"Castelli","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.01.061_BIB26","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0010-7824(85)90063-0","article-title":"Effect of long-term hormonal contraception on plasma lipids","volume":"31","author":"Deslypere","year":"1985","journal-title":"Contraception"},{"issue":"suppl","key":"10.1016\/j.ajog.2004.01.061_BIB27","first-page":"7","article-title":"Oral contraception: past, present, and future perspectives","volume":"36","author":"Mishell","year":"1991","journal-title":"Int J Fertil"},{"key":"10.1016\/j.ajog.2004.01.061_BIB28","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0002-9378(16)32483-8","article-title":"Progestogens in cardiovascular diseases: an introduction to the epidemiologic data","volume":"142","author":"Mann","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.01.061_BIB29","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/S0002-9378(94)05015-5","article-title":"Update on the metabolic effects of steroidal contraceptives and their relationship to cardiovascular disease risk","volume":"170","author":"Godsland","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.01.061_BIB30","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(95)12393-8","article-title":"Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study","volume":"348","author":"WHO","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2004.01.061_BIB31","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1161\/01.STR.29.11.2277","article-title":"Stroke and use of low-dose oral contraceptives in young women: a pooled analysis of two US studies","volume":"29","author":"Schwartz","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.ajog.2004.01.061_BIB32","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/bmj.306.6883.956","article-title":"Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study","volume":"306","author":"Lidegaard","year":"1993","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2004.01.061_BIB33","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1136\/bmj.315.7121.1502","article-title":"Case-control study of oral contraceptives and risk of thromboembolic stroke: results from international study on oral contraceptives and health of young women","volume":"315","author":"Heinegmann","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2004.01.061_BIB34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJM199607043350102","article-title":"Stroke in users of low-dose oral contraceptives","volume":"335","author":"Petitti","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2004.01.061_BIB35","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(95)12394-6","article-title":"Hemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicentre, case-control study","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2004.01.061_BIB36","series-title":"Estrogens and progestogens in clinical practice","first-page":"831","article-title":"The influence of steroids on gynecologic cancers","author":"Schlesselman","year":"1998"},{"issue":"Pt 1","key":"10.1016\/j.ajog.2004.01.061_BIB37","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0029-7844(95)00022-J","article-title":"Net effect of oral contraceptive use on the risk of cancer in women in the United States","volume":"85","author":"Schlesselman","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.01.061_BIB38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasice cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.ajog.2004.01.061_BIB39","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1006\/bbrc.1996.1080","article-title":"Differential effects of progestins and estrogens on long control regions of human papillomavirus types 16 and 18","volume":"224","author":"Chen","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajog.2004.01.061_BIB40","first-page":"937","article-title":"Integration of high-risk human papillomavirus DNA is linked to the down-regulation of class I human leukocyte antigens by steroid hormones in cervical tumor cells","volume":"57","author":"Bartholomew","year":"1997","journal-title":"Can Res"},{"key":"10.1016\/j.ajog.2004.01.061_BIB41","series-title":"Hormonal contraception and post-menopausal hormonal therapy. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans","author":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans","year":"1999"},{"key":"10.1016\/j.ajog.2004.01.061_BIB42","series-title":"Estrogens and progestogens in clinical practice","first-page":"555","article-title":"Clinical aspects of oral contraception","author":"Connell","year":"1998"},{"key":"10.1016\/j.ajog.2004.01.061_BIB43","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0010-7824(97)00023-1","article-title":"Combined oral contraceptives and liver disease","volume":"55","author":"Hannaford","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2004.01.061_BIB44","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1258\/0007142001903337","article-title":"Health consequences of combined oral contraceptives","volume":"56","author":"Hannaford","year":"2000","journal-title":"Br Med Bull"},{"key":"10.1016\/j.ajog.2004.01.061_BIB45","series-title":"Estrogens and progestogens in clinical practice","first-page":"865","article-title":"Influence of therapeutic steroids on the incidence and severity of breast cancer","author":"Hankinson","year":"1998"},{"key":"10.1016\/j.ajog.2004.01.061_BIB46","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","article-title":"Breast cancer and hormonal contraceptives: collaborative reanalysis of individual date on 53, 297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies","volume":"347","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2004.01.061_BIB47","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0010-7824(91)90002-W","article-title":"Biology of female sex hormone action in relation to contraceptive agents and neoplasia","volume":"43","author":"King","year":"1991","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2004.01.061_BIB48","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1056\/NEJM200101253440407","article-title":"Estrogen and the risk of breast cancer","volume":"344","author":"Clemons","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2004.01.061_BIB49","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1001\/jama.287.6.734","article-title":"Hormone replacement therapy in relation to breast cancer","volume":"287","author":"Chen","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2004.01.061_BIB50","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1054\/bjoc.2000.1622","article-title":"Oral contraceptives and colorectal cancer risk: a meta-analysis","volume":"84","author":"Fernandez","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajog.2004.01.061_BIB51","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1093\/humrep\/12.9.1851","article-title":"Risk of endometrial cancer in relation to use of combined oral contraceptives: a practitioner's guide to meta-analysis","volume":"12","author":"Schlesselman","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2004.01.061_BIB52","series-title":"DEVCAN: probability of developing or dying of cancer","author":"Feuer","year":"1999"},{"key":"10.1016\/j.ajog.2004.01.061_BIB53","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199407073310102","article-title":"Transient increase in the risk of breast cancer after giving birth","volume":"331","author":"Lambe","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2004.01.061_BIB54","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/aje\/153.11.1079","article-title":"Risk of late-stage breast cancer after childbirth","author":"Wohlfahrt","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2004.01.061_BIB55","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/oxfordjournals.aje.a010135","article-title":"Bias in the evaluation of low-magnitude associations: an empirical perspective","volume":"151","author":"Shapiro","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2004.01.061_BIB56","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0002-9343(81)90576-3","article-title":"Prostaglandins in primary dysmenorrhea. Comparison of prophylactic and nonprophylactic treatment with ibuprofen and use of oral contraceptives","volume":"70","author":"Chan","year":"1981","journal-title":"Am J Med"},{"key":"10.1016\/j.ajog.2004.01.061_BIB57","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0010-7824(90)90078-A","article-title":"The influence of different combined oral contraceptives on the prevalence and severity of dysmenorrhea","volume":"42","author":"Milsom","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2004.01.061_BIB58","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/00016348909087685","article-title":"The influence of a combined oral contraceptive on uterine activity and reactivity to agonists in primary dysmenorrhea","volume":"68","author":"Hauksson","year":"1989","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2004.01.061_BIB59","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0010-7824(92)90095-B","article-title":"The influence of a low-dose combined oral contraceptive on menstrual blood loss and iron status","volume":"46","author":"Larsson","year":"1992","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2004.01.061_BIB60","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/00016346709156829","article-title":"Clinical studies on oral contraceptives\u2014a randomized double-blind cross-over study of 4 different preparations: Anovlar mite, Lyndiol mite, Ovulen, and Volidan","volume":"Suppl 8","author":"Nilsson","year":"1967","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2004.01.061_BIB61","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0002-9378(71)90259-6","article-title":"Treatment of menorrhagia","volume":"110","author":"Nilsson","year":"1971","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.01.061_BIB62","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1479-828X.1991.tb02769.x","article-title":"Randomized trial of 2 hormonal and 2 prostaglandin-inhibition agents in women with a complaint of mehorrhagia","volume":"31","author":"Fraser","year":"1991","journal-title":"Aust NZ J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.01.061_BIB63","first-page":"913","article-title":"Triphasic norgestimate-ethinyl estradiol for treating dysfunctional uterine bleeding","volume":"96","author":"Davis","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.01.061_BIB64","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/BF01698138","article-title":"Iron status markers, serum ferritin and hemoglobin in 1359 Danish women in relation to menstruation, hormonal contraception, parity, and postmenopausal hormone treatment","volume":"65","author":"Milman","year":"1992","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ajog.2004.01.061_BIB65","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3109\/00016349309021150","article-title":"Iron status in Danish women aged 35-65 years: relation to menstruation and method of contraception","volume":"72","author":"Milman","year":"1993","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2004.01.061_BIB66","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s002770050405","article-title":"Iron status in 268 Danish women aged 18-30 years: influence of mestruation, contraceptive method, and iron supplementation","volume":"77","author":"Milman","year":"1998","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ajog.2004.01.061_BIB67","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/sj.ejcn.1600561","article-title":"Determining factors in the iron status of adult women in the SU.VI.MAX study. Supplementation en VItamines et Mineraux AntioXydants","volume":"52","author":"Galan","year":"1998","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.ajog.2004.01.061_BIB68","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jama.1974.03230260042022","article-title":"Functional ovarian cysts and oral contraceptives: negative association confirmed surgically","volume":"228","author":"Ory","year":"1974","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2004.01.061_BIB69","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0140-6736(77)92352-2","article-title":"Ovarian cysts and hormonal contraception","volume":"2","author":"Ylikorhala","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2004.01.061_BIB70","series-title":"A prospective study of the side effects of oral contraceptives","author":"Walnut Creek Contraceptive Drug Study","year":"1981"},{"key":"10.1016\/j.ajog.2004.01.061_BIB71","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1136\/bmj.294.6586.1518","article-title":"Ovarian neoplasms, functional ovarian cysts, and oral contraceptives","volume":"294","author":"Vessey","year":"1987","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.ajog.2004.01.061_BIB72","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/jech.46.5.528","article-title":"A case-control study of benign ovarian tumours","volume":"46","author":"Booth","year":"1992","journal-title":"J Epidemiol Comm Health"},{"key":"10.1016\/j.ajog.2004.01.061_BIB73","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/00001648-199609000-00019","article-title":"Risk factors for functional ovarian cysts","volume":"7","author":"Parazzini","year":"1996","journal-title":"Epidemiology"},{"key":"10.1016\/j.ajog.2004.01.061_BIB74","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0010-7824(97)00201-1","article-title":"Oral contraceptive use and benign gynecologic conditions: a review","volume":"57","author":"Chiaffarino","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2004.01.061_BIB75","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/0002-9378(92)91371-G","article-title":"Oral contraceptive type and functional ovarian cysts","volume":"166","author":"Lanes","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.01.061_BIB76","first-page":"29","article-title":"Ovulation and follicular development associated with three low-dose oral contraceptives: a randomized controlled trial","volume":"83","author":"Grimes","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.01.061_BIB77","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00003081-198906000-00019","article-title":"The health effects of oral contraceptives: misperceptions, controversies, and continuing good news","volume":"32","author":"Peterson","year":"1989","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.01.061_BIB78","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0010-7824(95)00221-9","article-title":"Contraception and the risk of ectopic pregnancy: a meta-analysis","volume":"52","author":"Mol","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2004.01.061_BIB79","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0015-0282(16)54647-0","article-title":"Oral contraceptives and breast disease","volume":"56","author":"McGonigle","year":"1991","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2004.01.061_BIB80","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00008469-199303000-00007","article-title":"Oral contraceptive use and risk of benign breast disease in a French case-control study of young women","volume":"2","author":"Charreau","year":"1993","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.ajog.2004.01.061_BIB81","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/(SICI)1097-0215(19990719)82:2<191::AID-IJC7>3.0.CO;2-F","article-title":"A cohort study of oral contraceptive use and risk of benign breast disease","volume":"82","author":"Rohan","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2004.01.061_BIB82","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00003081-200103000-00010","article-title":"Oral contraceptives: current status","volume":"44","author":"Burkman","year":"2001","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.01.061_BIB83","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/0002-9378(82)90430-6","article-title":"Oral contraceptives and pelvic inflammatory disease","volume":"144","author":"Rubin","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.01.061_BIB84","first-page":"233","article-title":"Laparoscopic findings and contraceptive use in women with signs and symptoms suggestive of acute salpingitis","volume":"66","author":"Wolner-Hansson","year":"1985","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.01.061_BIB85","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/jama.1990.03440010052029","article-title":"Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use","volume":"263","author":"Wolner-Hansson","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2004.01.061_BIB86","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0002-9378(97)70551-9","article-title":"Oral contraception and the recognition of endometritis","volume":"176","author":"Ness","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.01.061_BIB87","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1067\/mob.2001.115114","article-title":"Hormonal and barrier contraception and risk of upper genital tract disease in the PID Evaluation and Clinical Health (PEACH) Study","volume":"185","author":"Ness","year":"2001","journal-title":"Am J Obstet Gynecol"},{"issue":"Pt 1","key":"10.1016\/j.ajog.2004.01.061_BIB88","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0190-9622(97)70112-9","article-title":"Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris","volume":"37","author":"Lucky","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ajog.2004.01.061_BIB89","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0029-7844(97)00059-8","article-title":"Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial","volume":"89","author":"Redmond","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.01.061_BIB90","series-title":"Estrostep, NDA 21-276 Final labeling","year":"2001"},{"key":"10.1016\/j.ajog.2004.01.061_BIB91","first-page":"241","article-title":"Noncontraceptive benefits of oral contraceptive use: an evidence-based approach","volume":"45","author":"Williams","year":"2000","journal-title":"Int J Fertil Womens Med"},{"key":"10.1016\/j.ajog.2004.01.061_BIB92","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(98)09044-8","article-title":"Oral-contraceptive use and risk of hip fracture: a case-control study","volume":"353","author":"Michaelsson","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2004.01.061_BIB93","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0002-9378(00)70209-2","article-title":"Oral contraceptives and bone mineral density: a population-based study","volume":"182","author":"Pasco","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.01.061_BIB94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oxfordjournals.aje.a008846","article-title":"Controversy of oral contraceptives and risk of rheumatoid arthritis: meta-analysis of conflicting studies and review of conflicting meta-analyses with special emphasis on analysis of heterogeneity","volume":"144","author":"Pladevall-Vila","year":"1996","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2004.01.061_BIB95","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0889-8545(05)70169-8","article-title":"Health benefits of oral contraceptives","volume":"27","author":"Jensen","year":"2000","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.ajog.2004.01.061_BIB96","article-title":"Modern combined oral contraceptives for pain associated with endometriosis","volume":"2","author":"Moore","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2004.01.061_BIB97","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0039-128X(00)00177-X","article-title":"The levonorgestrel intrauterine system: therapeutic aspects","volume":"65","author":"Luukainen","year":"2000","journal-title":"Steroids"},{"key":"10.1016\/j.ajog.2004.01.061_BIB98","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0015-0282(00)01759-3","article-title":"Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis","volume":"75","author":"Fedel","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2004.01.061_BIB99","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0010-7824(95)00210-2","article-title":"Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties","volume":"52","author":"Luukainen","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2004.01.061_BIB100","doi-asserted-by":"crossref","first-page":"99S","DOI":"10.1016\/S0010-7824(98)00123-1","article-title":"An integrated analysis of vaginal bleeding patterns in clinical trials of Implanon","volume":"58","author":"Affandi","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2004.01.061_BIB101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0010-7824(99)00053-0","article-title":"A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant","volume":"60","author":"Zheng","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2004.01.061_BIB102","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0010-7824(01)00188-3","article-title":"Post-marketing surveillance of Norplant contraceptive implants: I, contraceptive efficacy and reproductive health","volume":"63","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2004.01.061_BIB103","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0889-8545(05)70171-6","article-title":"Injectable contraception: new and existing options","volume":"27","author":"Kaunitz","year":"2000","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.ajog.2004.01.061_BIB104","first-page":"529","article-title":"Functional ovarian cysts in relation to the use of monophasic and triphasic oral contraceptives","volume":"79","author":"Holt","year":"1992","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.01.061_BIB105","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0002-9378(11)91570-1","article-title":"A randomized, double-blind, placebo-controlled comparison of the impact of low-dose and Triphasic oral contraceptives on follicular development","volume":"167","author":"Young","year":"1992","journal-title":"Am J Obstet Gynecol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937804001437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937804001437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:38:12Z","timestamp":1757583492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937804001437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":105,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0002937804001437"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2004.01.061","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety concerns and health benefits associated with oral contraception","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2004.01.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}